Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Security class unavailable · CUSIP: 03969T109

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-24-001839
Form type
SC 13G/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Feb 05, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub